<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-TAM21116-4G5-CW-F93"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 S286 IS: Coronavirus Vaccine Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2021-02-08</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>117th CONGRESS</congress><session>1st Session</session><legis-num>S. 286</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20210208">February 8, 2021</action-date><action-desc><sponsor name-id="S369">Mr. Markey</sponsor> introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To conduct or support further comprehensive research for the creation of a universal coronavirus vaccine.</official-title></form><legis-body display-enacting-clause="yes-display-enacting-clause"><section section-type="section-one" id="S1"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Coronavirus Vaccine Act</short-title></quote>.</text></section><section id="id4CAF3FFE91034E62AE1B9940C8DAD2EB"><enum>2.</enum><header>Research for the creation of a universal coronavirus vaccine</header><subsection id="id902F753FC9E040C8AC62F533A28C5D68"><enum>(a)</enum><header>In general</header><text>The Director of the National Institute of Allergy and Infectious Diseases shall conduct or support comprehensive research for the creation of a universal coronavirus vaccine.</text></subsection><subsection id="id9491BCCB8D89443E8A7CE0C498A0B8AF"><enum>(b)</enum><header>Authorization of appropriations</header><text>To carry out this section, there are authorized to be appropriated $250,000,000 for each of fiscal years 2021 through 2024.</text></subsection></section></legis-body></bill>


